Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Alicia Ramirez Fernandez"'
Autor:
Jose L. Guerrero-Orriach, Alfredo Malo-Manso, Marta Ramirez-Aliaga, Ana Isabel Florez Vela, Manuel Galán-Ortega, Isabel Moreno-Cortes, Inmaculada Gonzalez-Almendros, Alicia Ramirez-Fernandez, Daniel Ariza-Villanueva, Juan Jose Escalona-Belmonte, Guillermo Quesada-Muñoz, Enrique Sepúlveda-Haro, Salvador Romero-Molina, Inmaculada Bellido-Estevez, Aurelio Gomez-Luque, Manuel Rubio-Navarro, Juan Alcaide-Torres, Concepcion Santiago-Fernandez, Lourdes Garrido-Sanchez, Jose Cruz-Mañas
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundLow-cardiac output syndrome (LCOS) after cardiac surgery secondary to systemic hypoperfusion is associated with a higher incidence of renal and neurological damage. A range of effective therapies are available for LCOS. The beneficial syste
Externí odkaz:
https://doaj.org/article/6470d5f90c97413dbb5c67f3fd6257a1
Autor:
Bernardo Herrera Imbroda, Maria Emilia Dominguez Recio, Julia Diaz Crespo, Angela M. Soriano Perez, Jose Cruz Mañas, Aida Raigon Ponferrada, Marta Ramirez Aliaga, Ana Fontaneda Heredia, Manuel Rubio Navarro, Alicia Ramirez Fernandez, Alfredo Malo Manso, Jose Luis Guerrero Orriach, Juan Jose Escalona Belmonte
Publikováno v:
Oncology. 98:161-167
Background:The effect of anesthetic techniques on cancer recurrence has been the subject of intensive research in the past years, as it affects a large proportion of the population. The use of opioids and halogenated agents in cancer patients during
Autor:
Rocío Bautista, Jose Luis Guerrero Orriach, Josefa Gómez Maldonado, Juan Jose Escalona Belmonte, Emilio Matute Gonzalez, Juan Alcaide Torres, Aida Raigon Ponferrada, Jose Cruz Mañas, Concepcion Santiago-Fernandez, Manuel Rubio Navarro, María José Capitán, Guillermo Quesada Muñoz, Alicia Ramirez Fernandez, Lourdes Garrido-Sánchez, Marta Ramirez Aliaga
Publikováno v:
Current Medicinal Chemistry. 27
Background:: Numerous studies have demonstrated that halogenated agents elicit myocardial conditioning effects when adminis-tered perioperatively in cardiac surgery. Recent evidence has been published of the benefits of maintaining exposure to haloge
Autor:
Manuel Rubio Navarro, Marta Ramirez Aliaga, Jose Luis Guerrero-Orriach, Juan Jose Escalona Belmonte, Jose Cruz Mañas, Alicia Ramirez Fernandez
Publikováno v:
Drug Design, Development and Therapy
Numerous studies have studied the effect of halogenated agents on the myocardium, highlighting the beneficial cardiac effect of the pharmacological mechanism (preconditioning and postconditioning) when employed before and after ischemia in patients w
Publikováno v:
Current vascular pharmacology. 17(6)
Autor:
Maria Emilia Dominguez Recio, Marta Ramirez Aliaga, Francisco J F García, Jose Cruz-Mañas, Alfredo Malo-Manso, J J Escalona-Belmonte, Jose Luis Guerrero-Orriach, Emilio A Conejo, Aida Raigon-Ponferrada, Alicia Ramirez Fernandez
Publikováno v:
Current pharmaceutical design. 25(28)
Breast cancer is a complex heterogeneous disease that is categorized into several histological and genomic subtypes with relevant prognostic and therapeutical implications. Such diversity requires a multidisciplinary approach for a comprehensive trea
Autor:
Jose Cruz Mañas, Jose Luis Guerrero Orriach, Juan Jose Escalona Belmonte, Alicia Ramirez Fernandez, Manuel Rubio Navarro, Marta Ramirez Aliaga, Aida Raigon Ponferrada
Publikováno v:
Current medicinal chemistry. 27(13)
Background: The pre- and post-conditioning effects of halogenated anesthetics make them most suitable for cardiac surgery. Several studies have demonstrated that the mechanism of drug-induced myocardial conditioning is enzyme-mediated via messenger R
Autor:
Alicia Ramirez-Fernandez, J L Guerrero Orriach, Manuel Rubio-Navarro, Jose Cruz-Mañas, J J Escalona-Belmonte
Publikováno v:
Current vascular pharmacology. 16(4)
Inodilators are a heterogeneous group of drugs with vasodilatory and inotropic effects. The cardioprotective effect of levosimendan is multifactorial, but now research on levosimendan is focused on the organ-protective properties of this drug in diff
Autor:
Manuel Galán-Ortega, Jose Cruz-Mañas, José María Melero-Tejedor, Manuel Rubio-Navarro, Lourdes Garrido-Sánchez, Alicia Ramirez-Fernandez, Concepción Santiago Fernandez, Daniel Ariza-Villanueva, Juan Alcaide Torres, Ana Florez-Vela, Isabel Navarro Arce, María Isabel Moreno-Cortés, Jose L Guerrero-Orriach
Publikováno v:
Therapeutics and Clinical Risk Management
José Luis Guerrero-Orriach,1 Daniel Ariza-Villanueva,1 Ana Florez-Vela,1 Lourdes Garrido-Sánchez,2,3 María Isabel Moreno-Cortés,1 Manuel Galán-Ortega,1 Alicia Ramírez-Fernández,1 Juan Alcaide Torres,3 Concepción Santiago Fernandez,3 Isabel Na